14-day Premium Trial Subscription Try For FreeTry Free

Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of NVCT
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Volatile ride for Nuvectis Pharma, Inc. stock price on Tuesday moving between $6.79 and $7.81
(Updated on May 07, 2024)

Sell candidate since May 06, 2024 Loss -4.89% PDF

The Nuvectis Pharma, Inc. stock price fell by -4.89% on the last day (Tuesday, 7th May 2024) from $7.56 to $7.19. During the last trading day the stock fluctuated 15.02% from a day low at $6.79 to a day high of $7.81. The price has fallen in 6 of the last 10 days but is still up by 9.1% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -24 thousand shares and in total, 161 thousand shares were bought and sold for approximately $1.16 million.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -17.23% during the next 3 months and, with a 90% probability hold a price between $4.89 and $8.11 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

NVCT Signals & Forecast

A buy signal was issued from a pivot bottom point on Tuesday, April 30, 2024, and so far it has risen 18.26%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Nuvectis Pharma, Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $7.49. On a fall, the stock will find some support from the short-term average at $6.97. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Support, Risk & Stop-loss for Nuvectis Pharma, Inc. stock

Nuvectis Pharma, Inc. finds support from accumulated volume at $7.03 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $1.02 between high and low, or 15.02%. For the last week the stock has had daily average volatility of 15.54%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (NVCT) For The Upcoming Trading Day Of Wednesday 8th

For the upcoming trading day on Wednesday, 8th we expect Nuvectis Pharma, Inc. to open at $7.26, and during the day (based on 14 day Average True Range), to move between $6.41 and $7.97, which gives a possible trading interval of +/-$0.783 (+/-10.88%) up or down from last closing price. If Nuvectis Pharma, Inc. takes out the full calculated possible swing range there will be an estimated 21.77% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $7.03 (2.23%) than the resistance at $7.46 (3.76%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Earnings coming up

Nuvectis Pharma, Inc. will release earnings BMO on Wednesday, May 08, 2024.The consensus among the analysts for the expected earnings (EPS) is -$0.400. We will update the financials statements for Nuvectis Pharma, Inc., that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 7.04% in the first trading day after earnings release.

Is Nuvectis Pharma, Inc. stock A Buy?

Nuvectis Pharma, Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -2.456 Sell Candidate Unchanged

Predicted Opening Price for Nuvectis Pharma, Inc. of Wednesday, May 8, 2024

Fair opening price May 8, 2024 Current price
$7.26 ( 1.02%) $7.19

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for NVCT

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 8.28 15.21 %
R2 7.89 9.79 %
R1 7.65 6.44 %
Current price: 7.19
Support S1 6.87 -4.40 %
S2 6.63 -7.75 %
S3 6.24 -13.17 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 8.77 21.97 %
R2 7.56 5.15 %
R1 7.46 3.76 %
Current price 7.19
Support S1 7.03 -2.23%
S2 6.41 -10.85%
S3 6.08 -15.44%

FAQ

What is the symbol for Nuvectis Pharma, Inc. Stock and on which exchange is it traded?
The symbol for Nuvectis Pharma, Inc. is NVCT and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Nuvectis Pharma, Inc. Stock?
Nuvectis Pharma, Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

How to buy Nuvectis Pharma, Inc. Stock?
Nuvectis Pharma, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Nuvectis Pharma, Inc. Stock.

What's the current price of Nuvectis Pharma, Inc. Stock?
As of the end of day on the May 07, 2024, the price of an Nuvectis Pharma, Inc. (NVCT) share was $7.19.

What is the 52-week high and low for Nuvectis Pharma, Inc. Stock?
The 52-week high for Nuvectis Pharma, Inc. Stock is $2.96 and the 52-week low is $0.265.

What is the market capitalization of Nuvectis Pharma, Inc. Stock?
As of the May 07, 2024, the market capitalization of Nuvectis Pharma, Inc. is 132.086M.

When is the next earnings date for Nuvectis Pharma, Inc.?
The upcoming earnings date for Nuvectis Pharma, Inc. is May 08, 2024.
Click to get the best stock tips daily for free!

About Nuvectis Pharma, Inc.

Nuvectis Pharma. Nuvectis Pharma, Inc., a biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious unmet medical needs in oncology. It develops NXP800, a novel heat shock factor 1 pathway inhibitor for the treatment of various cancers; and NXP900, a small molecule drug candidate to inhibit the Proto-oncogene c-Src and YES1 kinases. The company was incorporated in 2020 and is based in Fort Lee, New Jersey.... NVCT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT